Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2158-3188
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial ; volume:8 ; number:1 ; day:24 ; month:1 ; year:2018 ; pages:1-11 ; date:12.2018
Translational Psychiatry ; 8, Heft 1 (24.1.2018), 1-11, 12.2018

Keyword
Klinische Psychologie
Psychiatrie
Psychische Störung

Creator
Savitz, Jonathan B.
Contributor
Teague, T. Kent
Misaki, Masaya
Macaluso, Matt
Wurfel, Brent E.
Meyer, Matt
Drevets, Douglas
Yates, William
Gleason, Ondria
Drevets, Wayne C.
Preskorn, Sheldon H.
SpringerLink (Online service)

DOI
10.1038/s41398-017-0073-7
URN
urn:nbn:de:1111-201804137761
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Savitz, Jonathan B.
  • Teague, T. Kent
  • Misaki, Masaya
  • Macaluso, Matt
  • Wurfel, Brent E.
  • Meyer, Matt
  • Drevets, Douglas
  • Yates, William
  • Gleason, Ondria
  • Drevets, Wayne C.
  • Preskorn, Sheldon H.
  • SpringerLink (Online service)

Other Objects (12)

Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol

A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol

Aspirin Days (Aspirin days : )

Archivale

Aspirin Days (Aspirin days : )

Aspirin

Aspirin

Aspirin

Blechdose

Aspirin

Aspirin

Tablettenschachtel (Schmerztabletten)

Aspirin

Aspirin

Reklameschild

Aspirin

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Related objects